ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
5.25
0.00 (0.00%)
At close: Jul 6, 2026
ZIVO Bioscience Market Cap
ZIVO Bioscience has a market cap or net worth of $21.8 million as of July 7, 2026. Its market cap has decreased by -68.15% in one year.
Market Cap
21.80M
Enterprise Value
22.56M
Revenue
209.03K
Ranking
n/a
PE Ratio
n/a
Stock Price
$5.25
Market Cap Chart
Since October 30, 2003, ZIVO Bioscience's market cap has increased from 2.41M to 21.80M, an increase of 803.15%. That is a compound annual growth rate of 10.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 21.80M | -36.40% |
| Dec 31, 2025 | 34.27M | -55.05% |
| Dec 31, 2024 | 76.25M | 3,046.50% |
| Dec 29, 2023 | 2.42M | -89.71% |
| Dec 30, 2022 | 23.55M | -12.89% |
| Dec 31, 2021 | 27.03M | -56.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Provectus Biopharmaceuticals | 29.00M |
| EOM Pharmaceuticals Holdings | 25.30M |
| BetterLife Pharma | 21.13M |
| Oncotelic Therapeutics | 18.22M |
| Finch Therapeutics Group | 16.86M |
| Zenith Capital | 15.97M |
| Brainstorm Cell Therapeutics | 15.89M |
| Anebulo Pharmaceuticals | 15.50M |